Breaking News Instant updates and real-time market news.

HALO

Halozyme

$19.74

-0.62 (-3.05%)

09:31
01/17/18
01/17
09:31
01/17/18
09:31

Halozyme may be pressured on its ASCO-GI abstract, says BMO Capital

BMO Capital analyst Do Kim keeps the Market Perform rating and $18 price target on Halozyme, but warns that shares may be pressured after a "detailed SWOG PEGPH20+mFFOX data in an ASCO-GI abstract". Kim says investors may become more concerned with higher mortality in median OS of 7.6 months, as poor results could reduce confidence in the PEGPH20+AG pivotal trial.

  • 18

    Jan

HALO Halozyme
$19.74

-0.62 (-3.05%)

09/14/17
PIPR
09/14/17
NO CHANGE
Target $26
PIPR
Overweight
Halozyme price target raised to $26 from $20 at Piper Jaffray
09/15/17
DBAB
09/15/17
NO CHANGE
Target $20
DBAB
Buy
Halozyme price target raised to $20 from $17 at Deutsche Bank
Deutsche Bank analyst Andrew Peters raised his price target for Halozyme (HALO) to $20 saying he's bullish following the new Enhanze partnership. Yesterday's dual announcements for additional Enhanze collaborations are "clear positives" for the stock, Peters tells investors in a research note. He says the size of the Bristol-Myers Squibb deal, including the upfront payment, is larger than expected. The analyst reiterates a Buy rating on Halozyme.
11/22/17
LEHM
11/22/17
DOWNGRADE
Target $19
LEHM
Equal Weight
Halozyme assumed with an Equal Weight from Overweight at Barclays
Barclays analyst Gena Wang downgraded Halozyme Therapeutics to Equal Weight after assuming coverage of the name. The analyst raised her price target for the shares to $19 from $16. She believes the potential of Halozyme's Enhanze technology is largely reflected in the stock following the recent rally. Wang sees "some likelihood of success" for the company's wholly owned Phase 3 trial in pancreatic cancer reading out in Q4.
11/22/17
11/22/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Salesforce (CRM) downgraded to Neutral from Buy at Roth Capital with analyst Richard Baldry citing the 59% year-to-date rally in the shares. 2. Bloomin' Brands (BLMN) downgraded to Neutral from Buy at BofA/Merrill with analyst Gregory Francfort citing news of Jana Partners' 8.7% stake and subsequent share price spike. 3. Halozyme (HALO) assumed with an Equal Weight from Overweight at Barclays with analyst Gena Wang saying she believes the potential of Halozyme's Enhanze technology is largely reflected in the stock following the recent rally. 4. Mallinckrodt (MNK) downgraded to Perform from Outperform at Oppenheimer with analyst Derek Archila saying he's been "flat out wrong" on the shares. 5. Cytokinetics (CYTK) was downgraded to Neutral from Overweight at Cantor Fitzgerald and to Buy from Strong Buy at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CRON

Cronos Group

$6.91

0.18 (2.67%)

08:12
07/18/18
07/18
08:12
07/18/18
08:12
Hot Stocks
Cronos Group enters joint venture to expand cannabis production in Ontario »

Cronos Group has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

WAFD

Washington Federal

$32.90

-0.25 (-0.75%)

, ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

08:11
07/18/18
07/18
08:11
07/18/18
08:11
Hot Stocks
Washington Federal, Anchor Bancorp terminate merger agreement »

Washington Federal (WAFD)…

WAFD

Washington Federal

$32.90

-0.25 (-0.75%)

ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

AGS

PlayAGS

$27.94

-0.54 (-1.90%)

08:11
07/18/18
07/18
08:11
07/18/18
08:11
Recommendations
PlayAGS analyst commentary  »

PlayAGS price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 19

    Sep

CACI

CACI

$179.00

0.9 (0.51%)

08:09
07/18/18
07/18
08:09
07/18/18
08:09
Hot Stocks
CACI awarded task order with $122M ceiling by GSA »

CACI announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.11

0.21 (0.70%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Hot Stocks
Genpact to acquire Barkawi Management Consultants, terms not disclosed »

Genpact has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 07

    Aug

EXAS

Exact Sciences

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Recommendations
Exact Sciences analyst commentary  »

Exact Sciences price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 26

    Jul

  • 01

    Aug

  • 02

    Aug

NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

, EDIT

Editas Medicine

$36.46

1.31 (3.73%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Recommendations
Intellia Therapeutics, Editas Medicine, Crispr Therapeutics analyst commentary  »

Study in Nature Biotech…

NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

EDIT

Editas Medicine

$36.46

1.31 (3.73%)

CRSP

Crispr Therapeutics

$61.98

1.95 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

$42.54

-0.28 (-0.65%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Downgrade
American Campus rating change  »

American Campus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BA

Boeing

$356.95

0.94 (0.26%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Hot Stocks
Boeing subsidiary granted maintenance contract by Romanian Air Force »

Boeing subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PERY

Perry Ellis

$28.32

0.06 (0.21%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Hot Stocks
Perry Ellis special committee reiterates commitment to Feldenkreis transaction »

The special committee of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATOS

Atossa Genetics

$2.47

-0.1 (-3.89%)

08:06
07/18/18
07/18
08:06
07/18/18
08:06
Hot Stocks
Atossa Genetics announces intraductal microcatheter immunotherapy program »

Atossa Genetics …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$130.45

-0.34 (-0.26%)

08:06
07/18/18
07/18
08:06
07/18/18
08:06
Hot Stocks
Marriott removing plastic straws worldwide by July 2019 »

Marriott has adopted a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

NVEE

NV5 Global

$72.85

0.85 (1.18%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Hot Stocks
NV5 Global announces additional commissioning task order for U.S. Embassy »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

GTT

GTT Communications

$46.55

0.1 (0.22%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Hot Stocks
GTT Communications awarded three-year contract valued at $24M by DITCO »

GTT Communications has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAFD

Washington Federal

$32.90

-0.25 (-0.75%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Earnings
Washington Federal reports Q2 EPS 61c, consensus 59c »

Return on equity for Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

GWW

Grainger

$305.21

2.22 (0.73%)

08:05
07/18/18
07/18
08:05
07/18/18
08:05
Hot Stocks
Grainger CEO says 'The second quarter exceeded our expectations' »

"The second quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TWTR

Twitter

$44.70

0.45 (1.02%)

08:04
07/18/18
07/18
08:04
07/18/18
08:04
Hot Stocks
Bloomberg announces launch of Twitter feed optimized for trading »

Bloomberg announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FMNB

Farmers National Banc

$16.20

-0.2 (-1.22%)

08:04
07/18/18
07/18
08:04
07/18/18
08:04
Earnings
Farmers National Banc reports Q2 EPS 29c, consensus 28c »

Annualized return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDWR

Radware

$27.03

-0.23 (-0.84%)

08:04
07/18/18
07/18
08:04
07/18/18
08:04
Recommendations
Radware analyst commentary  »

Jefferies boosts target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

GWW

Grainger

$305.21

2.22 (0.73%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Earnings
Grainger raises FY18 EPS view to 15.05-$16.05 from $14.30-$15.30 »

FY18 consensus $15.01.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TRCO

Tribune Media

$33.30

1.25 (3.90%)

, SBGI

Sinclair Broadcast

$28.00

-1.1 (-3.78%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Recommendations
Tribune Media, Sinclair Broadcast analyst commentary  »

Tribune Media price…

TRCO

Tribune Media

$33.30

1.25 (3.90%)

SBGI

Sinclair Broadcast

$28.00

-1.1 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

CLNY

Colony Capital

$5.97

-0.11 (-1.81%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Hot Stocks
Colony Industrial acquires Yellow Brick Road portfolio in Baltimore »

Colony Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

IMMU

Immunomedics

$25.40

-0.09 (-0.35%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Hot Stocks
Immunomedics: FDA accepts BLA, grants priority review for sacituzumab govitecan »

Immunomedics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTI

Ultimate Software

$284.44

2.44 (0.87%)

08:03
07/18/18
07/18
08:03
07/18/18
08:03
Recommendations
Ultimate Software analyst commentary  »

Ultimate Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 31

    Jul

CATS

Catasys

$6.73

-0.015 (-0.22%)

, GE

General Electric

$13.70

-0.2 (-1.44%)

08:02
07/18/18
07/18
08:02
07/18/18
08:02
Hot Stocks
Catasys names Jeremiah Stone as Chief Technology Officer »

Catasys (CATS) announced…

CATS

Catasys

$6.73

-0.015 (-0.22%)

GE

General Electric

$13.70

-0.2 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.